-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalo Therapeutics CMO Mittie Doyle sells 679 common shares for $13,580

PUBT·09/01/2026 20:39:21
Listen to the news
Avalo Therapeutics CMO Mittie Doyle sells 679 common shares for $13,580
  • Avalo Therapeutics Chief Medical Officer Doyle Mittie sold 679 common shares at USD 20 on Aug. 28, 2026.
  • The sale followed the exercise of 679 stock options at USD 8.04 on the same date.
  • Mittie held 51,776 common shares after the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001918845-26-000031), on September 01, 2026, and is solely responsible for the information contained therein.